Phase II trial of ribociclib and letrozole in patients with relapsed oestrogen receptor-positive ovarian or endometrial cancers
利博西尼联合来曲唑治疗复发性雌激素受体阳性卵巢癌或子宫内膜癌患者的II期试验
期刊:ESMO Open
影响因子:8.3
doi:10.1136/esmoopen-2020-000926
Colon-Otero, Gerardo; Zanfagnin, Valentina; Hou, Xiaonan; Foster, Nathan R; Asmus, Erik J; Wahner Hendrickson, Andrea; Jatoi, Aminah; Block, Matthew S; Langstraat, Carrie L; Glaser, Gretchen E; Dinh, Tri A; Robertson, Matthew W; Camoriano, John K; Butler, Kristina A; Copland, John A; Weroha, S John